This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Postoperative Pain Control With Fentanyl Patch in Patients Undergoing Mastectomy and TRAM or DIEP Flap Reconstruction (Fentanyl Patch)

This study has been completed.
Information provided by:
University of California, San Francisco Identifier:
First received: December 9, 2010
Last updated: NA
Last verified: December 2010
History: No changes posted
The aim of this randomized, double-blind controlled trial is to determine the efficacy of transdermal fentanyl for the management of early postoperative pain in women undergoing mastectomy followed by immediate TRAM or DIEP flap reconstruction. We will examine whether the use of the fentanyl patch as a bridge between epidural and oral analgesia will improve overall pain relief compared to placebo patch. We further propose to study whether the fentanyl patch is associated with improved ability to sleep, patient satisfaction, and functional capacity at one week, and whether it is associated with different side effects than standard therapy without the patch. Following informed consent, patients will undergo mastectomy and reconstruction, and receive epidural fentanyl for initial postoperative analgesia. Patients will be randomized to active (25 mcg/hr Duragesic) or placebo patches on postoperative day three, and the epidural will be weaned over the next 12 hours. Pain intensity scores and relief from pain will be assessed every day while in the hospital and oral and IV opioid use recorded. Patients will be discharged to home with a supply of 2 patches and oral medication, and will be asked to fill out a daily pain and medication log.

Condition Intervention Phase
Postoperative Pain After Breast Reconstruction With Abdominal Flap Drug: Fentanyl Drug: Inactive patch Phase 4

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Primary Purpose: Treatment
Official Title: Postoperative Pain Control With Fentanyl Patch in Patients Undergoing Mastectomy and TRAM or DIEP Flap Reconstruction

Resource links provided by NLM:

Further study details as provided by University of California, San Francisco:

Primary Outcome Measures:
  • Opioid analgesic use [ Time Frame: 10-20 days ]
    Daily opioid use on immediate postoperative days while wearing patch

Secondary Outcome Measures:
  • Pain intensity [ Time Frame: 10-20 days ]
    Daily measure of pain intensity on 0-10 numeric rating scale on postoperative days

  • Relief from pain [ Time Frame: 10-20 days ]
    Daily measure of relief provided by pain medications on 0-100% scale on postoperative days

  • Adverse event questionnaire [ Time Frame: 10-20 days ]
    Daily measurement of headache, itching, nausea, vomiting, constipation, difficulty urinating, drowsiness, lightheadedness, indigestion

  • Functional assessment questionnaire [ Time Frame: 10-20 days ]
    Daily measure of how surgical pain has interfered with general activity, mood, walking ability, sleep, brushing teeth, interactions with other people and enjoyment of life on a 0-10 scale on postoperative days

Enrollment: 60
Study Start Date: February 2003
Study Completion Date: August 2007
Primary Completion Date: August 2007 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Active Comparator: Active fentanyl patch
25 mcg/hr fentanyl patch
Drug: Fentanyl
25 mcg/hr transdermal patch
Placebo Comparator: Placebo patch
Inactive patch that resembles treatment patch but contains no drug
Drug: Inactive patch
placebo patch (no drug)


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Undergoing breast reconstruction with abdominal flap
  • Provided written, informed consent

Exclusion Criteria:

  • Karnofsky performance status ≥80%
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01258296

United States, California
University of California, San Francisco
San Francisco, California, United States, 94143
Sponsors and Collaborators
University of California, San Francisco
Principal Investigator: Laura Esserman, MD University of California, San Francisco
Study Director: Laura Petrillo, BA University of California, San Francisco
  More Information

Responsible Party: Laura Esserman, University of California, San Francisco Identifier: NCT01258296     History of Changes
Other Study ID Numbers: UCSF-04804
Study First Received: December 9, 2010
Last Updated: December 9, 2010

Keywords provided by University of California, San Francisco:
Postoperative pain
Breast reconstruction
Abdominal flap breast reconstruction

Additional relevant MeSH terms:
Pain, Postoperative
Neurologic Manifestations
Nervous System Diseases
Postoperative Complications
Pathologic Processes
Signs and Symptoms
Analgesics, Opioid
Central Nervous System Depressants
Physiological Effects of Drugs
Sensory System Agents
Peripheral Nervous System Agents
Adjuvants, Anesthesia
Anesthetics, Intravenous
Anesthetics, General
Anesthetics processed this record on September 20, 2017